CyrusOne
CyrusOne Inc. (Form: 8-K, Received: 05/04/2017 17:06:44)



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 8-K
_______________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): April 28, 2017
_______________
CYRUSONE INC.
(Exact Name of Registrant as Specified in its Charter)
_______________

Maryland
 
001-35789
 
46-0691837
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
2101 Cedar Springs Road, Suite 900
Dallas, TX 75201
(Address of Principal Executive Office)
 
Registrant’s telephone number, including area code: (972) 350-0060
_______________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 





Item 5.07    Submission of Matters to a Vote of Security Holders.
 
On April 28, 2017, CyrusOne Inc. (the “Company”) held its 2017 Annual Meeting of Stockholders (the “Annual Meeting”). A total of 87,847,109 shares of common stock were entitled to vote as of the record date for the Annual Meeting, and there were 82,454,808 shares present in person or by proxy at the Annual Meeting. The final voting results are set forth below.
 
Proposal 1: The stockholders elected each of the eight director nominees to the Board of Directors of the Company to serve until the 2018 Annual Meeting of Stockholders, as follows:
 
 
 
 
Votes
 
Broker
 
 
 
Votes For
 
Withheld
 
Non-Votes
 
David H. Ferdman
 
76,519,636
 
575,534
 
5,359,638
 
John W. Gamble, Jr.
 
76,515,666
 
579,504
 
5,359,638
 
Michael A. Klayko
 
73,738,130
 
3,357,040
 
5,359,638
 
T. Tod Nielsen
 
74,078,700
 
3,016,470
 
5,359,638
 
Alex Shumate
 
74,474,777
 
2,620,393
 
5,359,638
 
William E. Sullivan
 
70,712,130
 
6,383,040
 
5,359,638
 
Lynn A. Wentworth
 
73,802,646
 
3,292,524
 
5,359,638
 
Gary J. Wojtaszek
 
76,518,452
 
576,718
 
5,359,638
 
 
Proposal 2: The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as follows:
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
 
40,330,685
 
36,619,459
 
145,026
 
5,359,638
 
 
Proposal 3: The stockholders ratified the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2017, as follows:
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
 
82,345,985
 
86,209
 
22,614
 
0
 


2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
CYRUSONE INC.
 
 
 
Date: May 4, 2017
By:
/s/ Robert M. Jackson
 
 
Robert M. Jackson
 
 
Executive Vice President, General Counsel and Secretary


3